Skip to Content

Join the 'Condylomata Acuminata' group to help and get support from people like you.

Condylomata Acuminata News

Related terms: Genital Warts, Condyloma, Venereal Warts

HPV Vaccine Linked to Drop in Cases of Rare Childhood Disease

Posted 13 days ago by Drugs.com

THURSDAY, Nov. 9, 2017 – The human papillomavirus (HPV) vaccine, first developed to help guard against cervical cancer, also seems to protect against a rare, chronic childhood respiratory disease, a new study suggests. It's believed that the disease – recurrent respiratory papillomatosis – occurs in children when HPV type 6 or 11 spreads from mother to child around the time of birth. Some children develop wart-like, noncancerous growths in the respiratory tract, making it difficult to breathe. The condition can be life-threatening, and repeated surgeries are usually required to keep the airway clear. In the United States, about 800 children develop recurrent respiratory papillomatosis each year. This results in annual medical costs of $123 million, according to a news release from the Journal of Infectious Diseases, which published the study on Nov. 9. For the study, researchers ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Gardasil, Viral Infection, Respiratory Tract Disease, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9

Oral Sex Plus Smoking a Cancer Danger for Men

Posted 20 Oct 2017 by Drugs.com

FRIDAY, Oct. 20, 2017 – Smoking and oral sex may be a deadly combo that raises a man's risk for head and neck cancer, a new study suggests. The key factor is transmission of oral strains of the cancer-linked human papillomavirus (HPV), which can be passed through oral sex. In fact, men who smoke and have five or more partners with whom they've had oral sex – in this study, that typically meant cunnilingus – have the highest risk of developing a type of head and neck cancer known as oropharyngeal cancer. Dr. Otis Brawley is chief medical officer at the American Cancer Society. Reviewing the new study, he noted that "the incidence of oral HPV infection seems to be rising among white men in their 50s and 60s," perhaps due to increasing acceptance of oral sex. Still, for most people, the risk of contracting an HPV-linked head-and-neck cancer remains very low, said lead researcher Amber ... Read more

Related support groups: Birth Control, Contraception, Plan B, Depo-Provera, Nexplanon, Mirena, NuvaRing, Provera, Sprintec, Implanon, Ortho Tri-Cyclen, Microgestin Fe 1/20, Tri-Sprintec, Yasmin, Plan B One-Step, Loestrin 24 Fe, Smoking, Ortho Evra, TriNessa, Mononessa

1 in 9 American Men Infected With Oral HPV

Posted 16 Oct 2017 by Drugs.com

MONDAY, Oct. 16, 2017 – Eleven million American men are infected with oral human papillomavirus (HPV), which can lead to cancers of the head, neck and throat, a new study reports. That equates to 1 in 9 U.S. males aged 18 to 69. And infection is most likely for those who have had multiple oral sexual partners, are gay or bisexual, or who also have genital HPV infection, a team of U.S. researchers found. The most common cancer caused by the sexually transmitted virus is oropharyngeal squamous cell carcinoma, a head and neck cancer that's far more common in men than women, according to the study. "The incidence of this cancer has increased 300 percent in the last 20 years," said lead researcher Ashish Deshmukh. He's a research assistant professor at the University of Florida College of Public Health and Health Professions. Deshmukh and colleagues used 2011-2014 data from the U.S. ... Read more

Related support groups: Cancer, Human Papilloma Virus, Condylomata Acuminata, Gardasil, Head and Neck Cancer, Human Papillomavirus Vaccine, Cervical Dysplasia, Human Papillomavirus Prophylaxis, Cervarix, Vaccination and Prophlaxis, Gardasil 9

HPV Test Alone OK for Cervical Cancer Screening Over 30: Expert Panel

Posted 12 Sep 2017 by Drugs.com

TUESDAY, Sept. 12, 2017 – An influential U.S. panel of health experts is boosting support for the HPV test as a routine part of cervical cancer screening. The independent U.S. Preventive Services Task Force (USPSTF) – which issues closely heeded guidelines on a range of medical issues – says the test for the human papillomavirus (HPV) can be used once every five years for women aged 30 to 65, in lieu of the once every three-year Pap test. Prior guidelines had called for the use of both tests together. For younger women, aged 21 to 29, a Pap test once every three years is still the recommended screen, the panel said. Certain strains of sexually transmitted HPV are thought to cause the vast majority of cervical cancer cases. "One of the biggest differences between these guidelines and the former guidelines is that the new guidelines recommend against co-testing – HPV test and a Pap ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Diagnosis and Investigation, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis, Gardasil 9

Health Tip: Getting the HPV Vaccine

Posted 30 Aug 2017 by Drugs.com

-- Human papillomavirus (HPV) is a sexually transmitted disease that has been linked to cancer of the cervix and a host of other cancers. The HPV vaccine is designed to prevent infection by the HPV-16 and HPV-18 strains of the virus, which are responsible for about 70 percent of cervical cancers, the American Cancer Society says. The virus also can lead to cancers of the anus, penis, vagina and throat. Here are the society's suggestions for who should get the vaccine, and when: The shot is best given when a person is age 11 or 12 because it produces the strongest immune response at this age. The vaccine also is recommended for unvaccinated females aged 13 to 26, and for unvaccinated males 13 to 21. Males 22 to 26 may also be vaccinated, but the shot is not as effective at these older ages. The vaccine is not approved nor recommended after age 26. While the shot is safe, it won't offer ... Read more

Related support groups: Sexually Transmitted Diseases, Human Papilloma Virus, Condylomata Acuminata, Gardasil, Human Papillomavirus Vaccine, Cervical Dysplasia, Human Papillomavirus Prophylaxis, Cervarix, Gardasil 9

Screening, HPV Vaccine Can Prevent Cervical Cancer: FDA

Posted 8 Feb 2017 by Drugs.com

TUESDAY, Feb. 7, 2017 – Women can reduce their risk of cervical cancer through vaccination and screening, the U.S. Food and Drug Administration says. In 2016, nearly 13,000 women in the United States will be diagnosed with cervical cancer and more than 4,100 will die from the disease, according to the U.S. National Cancer Institute. The FDA wants to make women aware of how to protect themselves from cervical cancer, which is caused by the human papillomavirus (HPV). An FDA-approved vaccine called Gardasil 9 protects against 9 HPV types and can prevent about 90 percent of cervical, vulvar, vaginal and anal cancer cancers, and also protects against genital warts. The vaccine is approved for use in females and males aged 9 to 26. Gardasil 9 is not a treatment for HPV disease or cervical cancer, noted Marion Gruber, director of the FDA's Office of Vaccines Research and Review. "Women, ... Read more

Related support groups: Cancer, Colorectal Cancer, Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Cervical Dysplasia, Human Papillomavirus Vaccine, Cervarix, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9, Urinary Tract Cancer

How Is the HPV Vaccine Perceived on Twitter?

Posted 18 Dec 2016 by Drugs.com

FRIDAY, Dec. 16, 2016 – Twitter conversations regarding the human papillomavirus (HPV) vaccine – which protects against sexually transmitted infections – tend to be positive, researchers say. Despite the vaccine's effectiveness, some oppose its use and voice their opinions on social media. So Drexel University researchers decided to assess what's being said on Twitter about the vaccine for preteens. They found more positive tweets than negative ones. "In our sample, I expected to see a large number of negative tweets based on traditional news coverage of the topic and because HPV can be portrayed as controversial because it brings together the fields of sexually transmitted infections, immunizations and cancer prevention," said study co-author Philip Massey. "But that wasn't the case on Twitter, we found." "It is always encouraging to see that more positive messages about health are ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Gardasil, Cervical Dysplasia, Human Papillomavirus Vaccine, Cervarix, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9

Two Doses of HPV Vaccine Effective for Younger Teens

Posted 22 Nov 2016 by Drugs.com

TUESDAY, Nov. 22, 2016 – New global research confirms that two doses of the vaccine for HPV, rather than three, can protect younger teens against the sexually transmitted virus. Based on this study and others, U.S. government health officials revised their guidelines last month to recommend a two-dose regimen for teens younger than 15. Prior to that revised guideline, three doses were recommended for adolescents and young adults up through 26 years of age. The vaccine protects against infection by HPV (human papillomavirus), which is the cause of 90 percent of cervical cancers, according to the U.S. National Cancer Institute. The new review included more than 1,500 young people, aged 9 to 26, who were vaccinated against HPV at 52 sites in 15 countries. For the study, the researchers gave two doses of HPV vaccine to teens aged 9 to 14, and three doses of the vaccine to older teens and ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9

Anal Cancer Rates Rising in Many Parts of the World

Posted 2 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 2, 2016 – Anal cancer rates are on the rise in many countries. But vaccination against human papillomavirus (HPV) – a virus linked to the development of anal cancer – may help curb rates of the disease, a new study suggests. Researchers looked at data from the International Agency for Research on Cancer. The data included 18 countries. The investigators found that anal cancer rates have been increasing in women and men in 13 of those countries, particularly Australia and other countries in the Americas, and northern and western Europe. In those countries, a major subtype called anal squamous cell carcinoma (ASCC) was much more common than others, and was the main reason for the overall increasing rates of anal cancer. Rates of another major subtype, anal adenocarcinoma (AAC), have been stable or decreasing in most populations, the researchers said. "The reason for the ... Read more

Related support groups: Cancer, Colorectal Cancer, Human Papilloma Virus, Anal Fissure and Fistula, Condylomata Acuminata, Gardasil, Anal Itching, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis, Gardasil 9

Kids 14 and Younger Only Need 2 HPV Vaccine Shots: CDC

Posted 20 Oct 2016 by Drugs.com

THURSDAY, Oct. 20, 2016 – Children 14 and younger require only two doses of the HPV vaccine rather than the previously recommended three shots, U.S. health officials now say. The vaccine protects against infection with sexually transmitted HPV (human papillomavirus), which can cause cervical and other cancers. On Wednesday, the Centers for Disease Control and Prevention recommended that 11- to 12-year-olds receive two doses of HPV vaccine at least six months apart. It also said teens 13 and 14 can be vaccinated on the two-dose schedule. However, those who start receiving the vaccinations later – at ages 15 to 26 – still need three doses of the vaccine, according to the updated guidelines. One cervical cancer expert called the new guidelines "very important." "Decreasing the number of shots from three to two will definitely increase the chances of compliance [with vaccination]," said ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Gardasil, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Vaccination and Prophlaxis, Gardasil 9

Are Fewer Cervical Cancer Screenings Needed After HPV Vaccine?

Posted 18 Oct 2016 by Drugs.com

MONDAY, Oct. 17, 2016 – Women who've been vaccinated against human papillomavirus (HPV) likely need fewer cervical cancer screenings, a new study argues. Just how often a woman needs a cervical cancer screening depends on the type of vaccine she had, the researchers said. Women vaccinated with earlier versions of the HPV vaccine – which protect against the two worst cancer-causing strains of the sexually transmitted virus – only need cervical cancer screening every five years starting at age 25 or 30, the study concluded. Women who've received the updated vaccine, which protects against seven cancer-causing strains of HPV, need screening even less often. The researchers recommend testing these women every 10 years starting at age 30 to 35 and ending at age 65. Both screening regimens would be much less rigorous than current guidelines, which call for cervical cancer exams from age 21 ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Gardasil, Cervical Cancer, Cervical Dysplasia, Human Papillomavirus Vaccine, Human Papillomavirus Prophylaxis, Cervarix, Gardasil 9

A Doctor's Words Key to Whether Child Gets HPV Vaccine

Posted 2 Oct 2016 by Drugs.com

FRIDAY, Sept. 30, 2016 – The language doctors use when recommending the human papillomavirus (HPV) vaccine can influence whether parents will have their children immunized, a new study finds. HPV causes most cases of cervical cancer and a large percentage of vaginal, vulvar, anal, penile and oropharyngeal cancers. The U.S. Centers for Disease Control and Prevention recommends boys and girls receive the three-dose HPV vaccination beginning at age 11 or 12. As of 2015, only 42 percent of girls and 28 percent of boys ages 13 to 17 had completed the HPV vaccine series, according to the CDC. Previous research found that doctors' recommendations play a major role in whether parents have their children vaccinated. In this new study, researchers examined if specific language used by doctors affects parents' decisions. The study included more than 1,500 parents. Their children were between the ... Read more

Related support groups: Cancer, Human Papilloma Virus, Condylomata Acuminata, Gardasil, Cervical Cancer, Head and Neck Cancer, Cervical Dysplasia, Human Papillomavirus Vaccine, Cervarix, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9

Cancer Experts Endorse CDC's HPV Vaccine Guidelines

Posted 19 Jul 2016 by Drugs.com

TUESDAY, July 19, 2016 – The American Cancer Society has endorsed the U.S. government's HPV vaccination recommendations, which include immunizing all preteens against the sexually transmitted human papilloma virus. In a new report, the cancer society says 11- and 12-year-old girls as well as boys should be vaccinated to guard against cancers associated with HPV. This is in line with updated guidelines from the federal Centers for Disease Control and Prevention. "HPV vaccination has the potential to prevent tens of thousands of cancers and hundreds of thousands of pre-cancers each year," said the lead author of the report, Debbie Saslow. She is the cancer society's director of cancer control intervention for HPV vaccination and women's cancers. "It is critical that all stakeholders – families, health care providers, and others – make HPV vaccination a priority, so that prevention of ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9

HPV-Linked Cancers Still Climbing in U.S.

Posted 9 Jul 2016 by Drugs.com

THURSDAY, July 7, 2016 – Cancers linked to the sexually transmitted human papillomavirus (HPV) keep rising in the United States, even though most cases are preventable, health officials reported Thursday. Cervical cancer, and mouth and throat cancers in men, accounted for most of the nearly 39,000 HPV-associated cancers diagnosed annually from 2008 to 2012, according to the U.S. Centers for Disease Control and Prevention. HPV vaccination and cervical cancer screening could keep more than 28,000 of these cancers from developing, the agency estimated. "Most cervical cancers are preventable with regular screening for precancerous lesions among women aged 21 to 65 years, linked with follow-up for abnormal test results," the CDC researchers wrote in the report. But cancer experts said that public perception may have to change first, especially with respect to HPV vaccination. "In order to ... Read more

Related support groups: Condylomata Acuminata, Gardasil, Human Papillomavirus Vaccine, Human Papillomavirus Prophylaxis, Cervarix, Vaccination and Prophlaxis, Gardasil 9, Haemophilus influenzae Prophylaxis

1st HPV Test for Use With Preservative Fluid

Posted 8 Jul 2016 by Drugs.com

FRIDAY, July 8, 2016 – The U.S. Food and Drug Administration has approved Roche's cobas HPV Test – the first diagnostic to be used with cervical cells obtained for a Pap test and collected in SurePath Preservative Fluid. SurePath is an FDA-approved liquid collection fluid that's frequently used for Pap tests. But until this latest approval, no human papillomavirus (HPV) test had been approved to be used with the fluid, the FDA said in a news release. HPV strains account for some 70 percent of cervical cancers globally. The U.S. National Cancer Institute estimates there will be nearly 13,000 new cases of cervical cancer detected this year, and the disease will cause more than 4,100 deaths. The Swiss drugmaker Roche in 2012 warned that using cervical cells in SurePath fluid with an existing HPV test could produce false-negative results, the FDA said. This could have led to lack of ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Gardasil, Diagnosis and Investigation, Cervical Dysplasia, Human Papillomavirus Vaccine, Cervarix, Human Papillomavirus Prophylaxis, Gardasil 9

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Human Papilloma Virus

Related Drug Support Groups

imiquimod, Aldara, Zyclara, podofilox, interferon alfa-2b, echinacea, Condylox, Intron A, Veregen, interferon alfa-n3, sinecatechins, Alferon N